TaiGen Biopharmaceuticals Holdings Ltd Sustainability Reports

TaiGen Biopharmaceuticals Holdings Limited is a biopharmaceutical company engaged in the research, development, and commercialization of innovative small-molecule novel drugs, primarily focusing on anti-infective therapies.

Sector: Manufacturing

Country: Taiwan

Exchange: Taipei Exchange

FIGI: BBG0055NWZ27

9 reports from 2019 to 2025

• TaiGen Biopharmaceuticals Holdings Ltd 2025 Consolidated Financial Statements and Independent Auditors' Report
• TaiGen Biopharmaceuticals Holdings Ltd 2024 Annual Report
• TaiGen Biopharmaceuticals Holdings Ltd 2024 Consolidated Financial Statements and Independent Auditors' Report
• TaiGen Biopharmaceuticals Holdings Ltd 2023 ESG Sustainability Report
• TaiGen Biopharmaceuticals Holdings Ltd 2022 ESG Sustainability Report